{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:21:06Z","timestamp":1791174066110,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.metabol.2003.07.013","type":"journal-article","created":{"date-parts":[[2003,12,12]],"date-time":"2003-12-12T11:09:12Z","timestamp":1071227352000},"page":"73-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":260,"title":["Antihyperglycemic effects of stevioside in type 2 diabetic subjects"],"prefix":"10.1016","volume":"53","author":[{"given":"S\u00f8ren","family":"Gregersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per B","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Hermansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2003.07.013_BIB1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/np50023a013","article-title":"Potential sweetening agent of plant origin III","volume":"45","author":"Soejarto","year":"1982","journal-title":"J Nat Prod"},{"key":"10.1016\/j.metabol.2003.07.013_BIB2","first-page":"771","article-title":"Effect of Stevia rebaudiana on glucose tolerance in normal adult humans","volume":"19","author":"Curi","year":"1986","journal-title":"Braz J Biol Res"},{"key":"10.1016\/j.metabol.2003.07.013_BIB3","first-page":"636","article-title":"Le principe a\u2019saveur sucree\u2032du Kaa\u2032-he\u2032-e\u2032","volume":"13","author":"Bridel","year":"1931","journal-title":"Bull Soc Chim Biol"},{"key":"10.1016\/j.metabol.2003.07.013_BIB4","first-page":"599","article-title":"Stevia rebaudiana Bertoni. Avaliacao do efeito hipoglicemiante em coelhos aloxanizados","volume":"29","author":"Schmeling","year":"1977","journal-title":"Ciencia Cultura"},{"key":"10.1016\/j.metabol.2003.07.013_BIB5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1078\/0944-7113-00081","article-title":"Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo","volume":"9","author":"Jeppesen","year":"2002","journal-title":"Phytomedicine"},{"key":"10.1016\/j.metabol.2003.07.013_BIB6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1053\/meta.2003.50058","article-title":"Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki (GK) rat","volume":"52","author":"Jeppesen","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2003.07.013_BIB7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0026-0495(00)91325-8","article-title":"Stevioside acts directly on pancreatic beta cells to secrete insulin","volume":"49","author":"Jeppesen","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2003.07.013_BIB8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00403296","article-title":"Sulphonylurea treatment of NIDDM patients with cardiovascular disease","volume":"39","author":"Leibowitz","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2003.07.013_BIB9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2125.2000.00260.x","article-title":"A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension","volume":"50","author":"Chan","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.metabol.2003.07.013_BIB10","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1210\/jcem-56-6-1306","article-title":"Diminished gastric inhibitory polypeptide (GIP) response to a meal in newly diagnosed type I (insulin dependent) diabetics","volume":"56","author":"Krarup","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2003.07.013_BIB11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/bj2070381","article-title":"Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33\u201339) of glicentin","volume":"207","author":"Holst","year":"1982","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2003.07.013_BIB12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2337\/diab.43.4.535","article-title":"Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man","volume":"43","author":"\u00d8rkov","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.07.013_BIB13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/np50083a024","article-title":"Renal excretion of stevioside in rats","volume":"55","author":"Melis","year":"1992","journal-title":"J Nat Prod"},{"key":"10.1016\/j.metabol.2003.07.013_BIB14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0378-8741(92)90046-T","article-title":"Stevioside effect on renal function of normal and hypertensive rats","volume":"36","author":"Melis","year":"1992","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.metabol.2003.07.013_BIB15","first-page":"111","article-title":"Influence of stevioside on hepatic glycogen levels in fasted rats","volume":"84","author":"Hubler","year":"1994","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.metabol.2003.07.013_BIB16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1139\/y97-113","article-title":"The effect of stevioside on glucose metabolism in rat","volume":"75","author":"Suanarunsawat","year":"1997","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.metabol.2003.07.013_BIB17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/s-2007-999238","article-title":"Effect of cyclamate sodium, saccharin sodium and stevioside on arginine-induced insulin and glucagon secretion in the isolated perfused rat pancreas","volume":"12","author":"Usami","year":"1980","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2003.07.013_BIB18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2337\/diab.36.3.274","article-title":"Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics","volume":"36","author":"Baron","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.07.013_BIB19","first-page":"4053","article-title":"Lack of suppression of glucagons contributes to post-prandial hyperglycaemia in subjects with type 2 diabetes mellitus","volume":"85","author":"Shah","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2003.07.013_BIB20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1139\/y98-123","article-title":"Inhibitory effect of gymnemic acid on intestinal absorption of oleic acid in rats","volume":"76","author":"Wang","year":"1998","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049503003871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049503003871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:58:53Z","timestamp":1758419933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049503003871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0026049503003871"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2003.07.013","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihyperglycemic effects of stevioside in type 2 diabetic subjects","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2003.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}